From r-help-bounces@stat.math.ethz.ch  Fri Jun 15 17:44:50 2007
Return-Path: <r-help-bounces@stat.math.ethz.ch>
Received: from hypatia.math.ethz.ch (hypatia.math.ethz.ch [129.132.145.15])
	by flax9.uwaterloo.ca (8.12.8/8.12.5) with ESMTP id l5FLimL9007023
	for <ktwarwic@flax9.uwaterloo.ca>; Fri, 15 Jun 2007 17:44:49 -0400
Received: from hypatia.math.ethz.ch (hypatia [129.132.145.15])
	by hypatia.math.ethz.ch (8.13.6/8.13.6) with ESMTP id l5FLgter001000;
	Fri, 15 Jun 2007 23:43:25 +0200
X-Spam-Checker-Version: SpamAssassin 3.2.0 (2007-05-01) on hypatia.math.ethz.ch
X-Spam-Level: 
X-Spam-Status: No, score=0.1 required=5.0 tests=AWL, BAYES_50, DKIM_SIGNED,
	DKIM_VERIFIED autolearn=no version=3.2.0
Received: from web32802.mail.mud.yahoo.com (web32802.mail.mud.yahoo.com
	[68.142.206.32])
	by hypatia.math.ethz.ch (8.13.6/8.13.6) with SMTP id l5FK44kH003123
	for <r-help@stat.math.ethz.ch>; Fri, 15 Jun 2007 22:04:05 +0200
Received: (qmail 83884 invoked by uid 60001); 15 Jun 2007 19:43:55 -0000
X-YMail-OSG: _Cvf.nAVM1ls4gAdLL9jnhXpGmQggExp9bT7Q3Z9brdXxn9eoB7ETUyELG4XtrRT3eZgOBOvmorHBSfaZuwO9oT_P7.Y1.84Cbz_hFMMHkv9yhQsk9rRNPhoV.Smrw--
Received: from [130.15.106.174] by web32802.mail.mud.yahoo.com via HTTP;
	Fri, 15 Jun 2007 15:43:55 EDT
Date: Fri, 15 Jun 2007 15:43:55 -0400 (EDT)
From: John Kane <jrkrideau@yahoo.ca>
To: Spielas Bates <bates@stat.wisc.edu>,
   Nicholas Lewin-Koh <nikko@hailmail.net>
In-Reply-To: <40e66e0b0706151230o1e3a8f49va55f28f4e9cb689d@mail.gmail.com>
MIME-Version: 1.0
Message-ID: <417847.83261.qm@web32802.mail.mud.yahoo.com>
X-Virus-Scanned: by amavisd-new at stat.math.ethz.ch
Cc: r-help@stat.math.ethz.ch
Subject: Re: [R] R vs. Splus in Pharma/Devices Industry
X-BeenThere: r-help@stat.math.ethz.ch
X-Mailman-Version: 2.1.9
Precedence: list
List-Id: "Main R Mailing List: Primary help" <r-help.stat.math.ethz.ch>
List-Unsubscribe: <https://stat.ethz.ch/mailman/listinfo/r-help>,
	<mailto:r-help-request@stat.math.ethz.ch?subject=unsubscribe>
List-Archive: <https://stat.ethz.ch/pipermail/r-help>
List-Post: <mailto:r-help@stat.math.ethz.ch>
List-Help: <mailto:r-help-request@stat.math.ethz.ch?subject=help>
List-Subscribe: <https://stat.ethz.ch/mailman/listinfo/r-help>,
	<mailto:r-help-request@stat.math.ethz.ch?subject=subscribe>
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7bit
Sender: r-help-bounces@stat.math.ethz.ch
Errors-To: r-help-bounces@stat.math.ethz.ch


--- Spielas Bates <bates@stat.wisc.edu> wrote:

> On 6/15/07, Nicholas Lewin-Koh <nikko@hailmail.net>
> wrote:
> > Hi,
> > I just saw this thread. This issue, and the larger
> scale issue of open
> > source in industry
> > is being addressed. One has to realize that the
> behemoth that is the
> > clinical aperatus
> > of the pharma industry is very conservative and
> very slow to change. In
> > many cases
> > switching to R would meean changing a great many
> processes all based on
> > legacy code. One
> > of the big issues is that the industry demands
> consistency not
> > necessarily correctness.
> >
> > All that said there are a great many areas where R
> could be used that
> > would not impact
> > regulatory submission, data security etc. Many in
> pharma are quietly
> > working on this,
> > but steps are small and incremental. Development
> takes time in industry
> > because of the amount of
> > documentation necessary. All this impacts the
> "free" nature of R and
> > cost and risk (From the industries
> > perspective) need to be justified.
> 
> > Probably when the statistical community is using Z
> big pharma will be
> > ready to use
> > R. %P
> 
> I think you mean A, not Z.  First there was S, then
> there was R.

We're regressing !!!!

______________________________________________
R-help@stat.math.ethz.ch mailing list
https://stat.ethz.ch/mailman/listinfo/r-help
PLEASE do read the posting guide http://www.R-project.org/posting-guide.html
and provide commented, minimal, self-contained, reproducible code.

